Eyecare products company Bausch + Lomb files for IPO




  • In Business
  • 2022-01-14 15:12:05Z
  • By Axios
 

Bausch + Lomb, a Canadian maker of contact lenses and eyecare products, filed for an IPO.

Why it matters: This could be the first mega-IPO of 2022, with Renaissance Capital estimating that the issuer could raise up to $3 billion.

Get market news worthy of your time with Axios Markets. Subscribe for free.

Details: Bausch + Lomb plans to list on both the NYSE and Toronto Stock Exchange, and reports $139 million of net income on over $2.7 billion in revenue for the first nine months of 2021.

Backstory: Reports first surfaced last March that parent company Bausch Health (NYSE: BHC) was seeking to sell all or part of the eyecare business, which it bought from Warburg Pincus for $8.7 billion in 2013, with price talk in the $20 billion to $30 billion range.

  • It confirmed spinoff plans in August, shortly after which there was a direct listing by Warby Parker, which has begun to expand into contact lenses.

The bottom line: "Founded in 1853, Bausch & Lomb is an iconic name in eye care. The company invented Ray-Ban sunglasses for military pilots and later introduced some of the first mass-produced soft contact lenses and contact-lens solutions." - Wall Street Journal

Go deeper: Private equity giant TPG (finally) goes public

COMMENTS

More Related News

Canadian Oil Companies Are Spending On Dividends Rather Than Expansion
Canadian Oil Companies Are Spending On Dividends Rather Than Expansion

Canadian oil companies are enjoying a rare cash-rich moment, and they're focused on boosting shareholder value rather than expansion as oil prices remain...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business